Tenofovir disoproxil fumarate associated Fanconi syndrome in an HIV-uninfected man receiving HIV pre-exposure prophylaxis

被引：0
|
作者：
Dube, M. P. [1 ]
Funk, C. A. [1 ]
Corado, K. [2 ]
Morris, S. [3 ]
机构：
[1] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[2] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Los Angeles, CA USA
[3] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA
来源：
ANTIVIRAL THERAPY | 2016年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
A57
引用
收藏
页码：A57 / A57
页数：1
相关论文
共 50 条
  • [1] Tenofovir Disoproxil Fumarate-Associated Fanconi Syndrome in an Human Immunodeficiency Virus (HIV)-Uninfected Man Receiving HIV Pre-Exposure Prophylaxis
    Khan, Soheh
    Funk, Connie A.
    Corado, Katya
    Morris, Sheldon
    Dube, Michael P.
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (03):
  • [2] Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals
    Jotwani, Vasantha
    Scherzer, Rebecca
    Glidden, David V.
    Mehrotra, Megha
    Defechereux, Patricia
    Liu, Albert
    Gandhi, Monica
    Bennett, Michael
    Coca, Steven G.
    Parikh, Chirag R.
    Grant, Robert M.
    Shlipak, Michael G.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2018, 78 (02) : 169 - 174
  • [3] Safety of oral tenofovir disoproxil fumarate-based HIV pre-exposure prophylaxis use in lactating HIV-uninfected women
    Mugwanya, Kenneth K.
    John-Stewart, Grace
    Baeten, Jared
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (07) : 867 - 871
  • [4] Frequency of Monitoring Kidney Function in HIV-Uninfected Persons Using Daily Oral Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis
    Mugwanya, Kenneth K.
    Baeten, Jared M.
    Wyatt, Christina
    Mugo, Nelly R.
    Celum, Connie L.
    Ronald, Allan
    Kiarie, John
    Katabira, Elly
    Heffron, Renee
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2018, 77 (02) : 206 - 211
  • [5] Optimizing the frequency of kidney safety monitoring in HIV-uninfected persons using daily oral tenofovir disoproxil fumarate pre-exposure prophylaxis
    Mugwanya, K.
    Heffron, R.
    Wyatt, C.
    Mugo, N.
    Celum, C.
    Kiarie, J.
    Katabira, E.
    Ronald, A.
    Baeten, J.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [6] Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis
    Mugwanya, Kenneth K.
    Wyatt, Christina
    Celum, Connie
    Donnell, Deborah
    Kiarie, James
    Ronald, Allan
    Baeten, Jared M.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 71 (04) : 374 - 380
  • [7] Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention
    Mugwanya, Kenneth K.
    Baeten, Jared M.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (02) : 265 - 273
  • [8] Design and evaluation of mucoadhesive vaginal tablets of tenofovir disoproxil fumarate for pre-exposure prophylaxis of HIV
    Khan, Arshad Bashir
    Thakur, Ram Sharnagat
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2018, 44 (03) : 472 - 483
  • [9] Emtricitabine/Tenofovir Disoproxil Fumarate: A Review of its Use in HIV-1 Pre-Exposure Prophylaxis
    Greg L. Plosker
    Drugs, 2013, 73 : 279 - 291
  • [10] HIV prevention: response to pre-exposure prophylaxis failure with tenofovir disoproxil
    Fox, Julie
    Collins, Simon
    AIDS, 2017, 31 (09) : 1343 - 1343
12345